Full name
"APMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -0,1 | -0 | 90,5 |
Gross profit (loss) | 0 | -0,1 | -0,1 | 50,4 |
EBITDA | 0 | -0,1 | -0 | 92,6 |
Short time liabilities | 0,8 | 1 | 1,1 | 10,1 |
Other operating costs | 0 | 0 | 0 | -23,4 |
Equity capital | 0,3 | 0,2 | 0,1 | -28,4 |
Operating profit (EBIT) | 0 | -0,1 | -0 | 67,2 |
Assets | 1,2 | 1,2 | 1,3 | 3,4 |
Net profit (loss) | -0 | -0,1 | -0,1 | 51,5 |
Cash | 0 | 0 | 0 | 9,3 |
Net income from sale | 4,1 | 4,5 | 5,3 | 15,9 |
Liabilities and provisions for liabilities | 0,8 | 1 | 1,1 | 9,3 |
Working assets | 1 | 1,1 | 1,2 | 5,9 |
Other income costs | 0 | 0 | 0 | 350,2 |
Depreciation | 0 | 0 | 0 | 11,7 |
% | % | % | p.p. | |
Profitability of capital | -0,1 | -58,5 | -39,7 | 18,8 |
Equity capital to total assets | 26,5 | 15,5 | 10,8 | -4,7 |
Gross profit margin | 0 | -2,4 | -1 | 1,4 |
EBITDA Margin | 0,5 | -1,8 | -0,1 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 72 | 80 | 76 | -4 |
Current financial liquidity indicator | 1.2465183734893799 | 1.1099478006362915 | 1.0676262378692627 | 0 |
Net dept to EBITDA | -0.7958419919013977 | 0.1731523722410202 | 2.5653843879699707 | 2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane